Melanocytic nevus screening

Melanocytic nevus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Melanocytic Nevus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Melanocytic nevus screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Melanocytic nevus screening All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Melanocytic nevus screening
CDC on Melanocytic nevus screening
Melanocytic nevus screening in the news
Blogs on Melanocytic nevus screening
Directions to Hospitals Treating Melanocytic nevus
Risk calculators and risk factors for Melanocytic nevus screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]

Screening

• The presence of several melanocytic naevi is a strong risk factor for melanoma.
• In case of presence of numerous melanocytic naevi, one may perform whole body naevus count to identify at-risk patients.
• Two methods to count the nevus are used, whole body nevus count or the site-specific count.